Pomanda estimates the enterprise value of BIOSITE SYSTEMS LIMITED at £20.7m based on a Turnover of £15.9m and 1.3x industry multiple (adjusted for size and gross margin).
biosite systems limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of BIOSITE SYSTEMS LIMITED at £0 based on an EBITDA of £-433.7k and a 7.49x industry multiple (adjusted for size and gross margin).
biosite systems limitedEstimated Valuation
£11.7m
Pomanda estimates the enterprise value of BIOSITE SYSTEMS LIMITED at £11.7m based on Net Assets of £5.9m and 1.99x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biosite Systems LimitedOverview
Biosite Systems Limited is a live company located in solihull, B90 4NG with a Companies House number of 07308880. It operates in the manufacture of communication equipment other than telegraph, and telephone apparatus and equipment sector, SIC Code 26309. Founded in July 2010, it's largest shareholder is
pattern analytics ltd
with a 100% stake. Biosite Systems Limited is a established,
mid sized company, Pomanda has estimated its turnover at
£15.9m with
high
growth in recent years.
Pomanda's financial health check has awarded Biosite Systems Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
5 Strong
1 Regular
6 Weak
Size
annual sales of £15.9m, make it larger than the average company (£6.5m)
£15.9m - Biosite Systems Limited
£6.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 19%, show it is growing at a faster rate (8.5%)
19% - Biosite Systems Limited
8.5% - Industry AVG
Production
with a gross margin of 67.8%, this company has a lower cost of product (51.1%)
67.8% - Biosite Systems Limited
51.1% - Industry AVG
Profitability
an operating margin of -3.6% make it less profitable than the average company (4.3%)
-3.6% - Biosite Systems Limited
4.3% - Industry AVG
Employees
with 177 employees, this is above the industry average (43)
177 - Biosite Systems Limited
43 - Industry AVG
Pay Structure
on an average salary of £52.1k, the company has an equivalent pay structure (£60k)
£52.1k - Biosite Systems Limited
£60k - Industry AVG
Efficiency
resulting in sales per employee of £89.7k, this is less efficient (£147.3k)
£89.7k - Biosite Systems Limited
£147.3k - Industry AVG
Debtor Days
it gets paid by customers after 126 days, this is later than average (61 days)
126 days - Biosite Systems Limited
61 days - Industry AVG
Creditor Days
its suppliers are paid after 31 days, this is quicker than average (44 days)
31 days - Biosite Systems Limited
44 days - Industry AVG
Stock Days
it holds stock equivalent to 178 days, this is more than average (69 days)
178 days - Biosite Systems Limited
69 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 2 weeks, this is less cash available to meet short term requirements (19 weeks)
2 weeks - Biosite Systems Limited
19 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 39.3%, this is a lower level of debt than the average (53.6%)
39.3% - Biosite Systems Limited
53.6% - Industry AVG
BIOSITE SYSTEMS LIMITED financials
EXPORT
Biosite Systems Limited's latest turnover from December 2023 is £15.9 million and the company has net assets of £5.9 million. According to their latest financial statements, Biosite Systems Limited has 177 employees and maintains cash reserves of £191.4 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Jul 2021
Jul 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Jul 2015
Jul 2014
Jul 2013
Jul 2012
Jul 2011
Turnover
15,877,050
23,194,830
14,041,215
9,507,276
8,462,614
6,596,272
3,982,291
7,447,590
3,043,064
2,488,087
326,257
311,097
68,320
Other Income Or Grants
Cost Of Sales
5,113,619
7,265,448
3,600,139
4,184,171
4,421,974
3,909,906
2,259,106
3,603,069
1,509,744
1,229,021
161,829
153,363
33,797
Gross Profit
10,763,431
15,929,382
10,441,076
5,323,105
4,040,640
2,686,366
1,723,185
3,844,521
1,533,320
1,259,066
164,428
157,734
34,523
Admin Expenses
11,338,180
12,932,521
8,123,167
6,437,001
4,269,898
3,357,881
1,549,836
3,654,314
1,310,518
1,155,420
71,199
-102,478
14,963
Operating Profit
-574,749
2,996,861
2,317,909
-1,113,896
-229,258
-671,515
173,349
190,207
222,802
103,646
93,229
260,212
19,560
Interest Payable
29,585
12,559
26,505
47,969
52,315
43,899
30,505
Interest Receivable
4,802
2,075
6,423
1,122
1,202
893
809
910
1,183
896
281
Pre-Tax Profit
-599,532
2,984,302
2,291,404
-1,852,038
-275,150
-714,292
144,046
191,100
223,611
104,556
94,412
261,108
19,841
Tax
-194,010
-390,903
-155,444
407,697
381,758
204,380
57,633
-38,220
-44,722
-21,957
-21,715
-62,666
-5,159
Profit After Tax
-793,542
2,593,399
2,135,960
-1,444,341
106,608
-509,912
201,679
152,880
178,889
82,599
72,697
198,442
14,682
Dividends Paid
Retained Profit
-793,542
2,593,399
2,135,960
-1,444,341
106,608
-509,912
201,679
152,880
178,889
82,599
72,697
198,442
14,682
Employee Costs
9,214,104
9,746,221
6,234,579
6,209,899
4,786,666
3,677,921
2,381,798
3,394,052
1,338,343
1,053,728
133,008
133,415
43,403
Number Of Employees
177
168
133
126
104
83
53
75
30
24
3
3
1
EBITDA*
-433,731
3,228,606
2,578,758
-805,629
82,285
-414,979
337,275
249,806
266,997
119,576
102,141
266,660
20,915
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Jul 2021
Jul 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Jul 2015
Jul 2014
Jul 2013
Jul 2012
Jul 2011
Tangible Assets
435,241
319,340
433,714
627,091
874,826
954,962
790,322
379,264
108,538
6,133
5,918
5,095
1,354
Intangible Assets
407,980
13,333
25,000
Investments & Other
147,480
355,960
147,980
555,960
555,960
147,980
500
500
40,000
40,000
40,000
20,000
Debtors (Due After 1 year)
Total Fixed Assets
582,721
675,300
989,674
1,183,051
1,430,786
1,102,942
790,822
379,764
161,871
71,133
45,918
25,095
1,354
Stock & work in progress
2,496,358
3,698,382
2,212,157
1,322,054
1,294,480
1,282,629
665,553
229,151
75,000
Trade Debtors
5,506,040
5,305,524
4,522,273
3,992,895
3,250,576
2,179,956
1,761,580
1,711,707
740,141
480,488
58,935
46,063
9,228
Group Debtors
253,725
389,502
323,844
84,183
98,433
Misc Debtors
665,780
1,207,968
677,985
600,745
591,737
290,090
Cash
191,392
1,779,677
1,178,079
1,134,090
927,927
1,558,594
170,241
186,869
136,832
227,111
246,137
112,209
misc current assets
total current assets
9,113,295
10,601,376
9,192,092
7,417,617
6,355,066
4,779,035
3,985,727
2,111,099
1,002,010
617,320
286,046
292,200
121,437
total assets
9,696,016
11,276,676
10,181,766
8,600,668
7,785,852
5,881,977
4,776,549
2,490,863
1,163,881
688,453
331,964
317,295
122,791
Bank overdraft
1,502,331
2,425,421
2,425,421
471,273
1,055,243
Bank loan
Trade Creditors
436,491
1,043,790
735,154
468,686
800,140
690,299
506,653
1,706,231
581,057
318,506
44,659
102,852
36,934
Group/Directors Accounts
265,410
1,013,605
312,770
239,928
2,771,034
other short term finances
hp & lease commitments
110,859
227,051
221,486
136,972
other current liabilities
3,374,150
2,031,638
2,450,263
2,369,320
2,075,195
1,179,311
916,787
total current liabilities
3,810,641
4,577,759
5,876,248
6,387,891
3,886,429
3,386,267
4,331,446
1,706,231
581,057
318,506
44,659
102,852
36,934
loans
2,496,172
hp & lease commitments
43,219
159,250
221,105
202,935
Accruals and Deferred Income
other liabilities
44,738
18,823
70,925
provisions
20,000
20,000
20,000
146,274
46,177
39,405
16,392
1,227
1,184
1,019
total long term liabilities
20,000
20,000
63,219
305,524
2,763,454
202,935
84,143
35,215
1,227
1,184
1,019
70,925
total liabilities
3,810,641
4,597,759
5,896,248
6,451,110
4,191,953
6,149,721
4,534,381
1,790,374
616,272
319,733
45,843
103,871
107,859
net assets
5,885,375
6,678,917
4,285,518
2,149,558
3,593,899
-267,744
242,168
700,489
547,609
368,720
286,121
213,424
14,932
total shareholders funds
5,885,375
6,678,917
4,285,518
2,149,558
3,593,899
-267,744
242,168
700,489
547,609
368,720
286,121
213,424
14,932
Dec 2023
Dec 2022
Jul 2021
Jul 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Jul 2015
Jul 2014
Jul 2013
Jul 2012
Jul 2011
Operating Activities
Operating Profit
-574,749
2,996,861
2,317,909
-1,113,896
-229,258
-671,515
173,349
190,207
222,802
103,646
93,229
260,212
19,560
Depreciation
141,018
231,745
260,849
308,267
311,543
256,536
163,926
40,266
32,528
5,930
8,912
6,448
1,355
Amortisation
19,333
11,667
10,000
Tax
-194,010
-390,903
-155,444
407,697
381,758
204,380
57,633
-38,220
-44,722
-21,957
-21,715
-62,666
-5,159
Stock
-1,202,024
1,486,225
890,103
27,574
11,851
617,076
436,402
154,151
75,000
Debtors
-477,449
1,702,736
282,774
990,988
1,358,017
806,899
49,873
971,566
259,653
421,553
12,872
36,835
9,228
Creditors
-607,299
308,636
266,468
-331,454
109,841
183,646
-1,199,578
1,125,174
262,551
273,847
-58,193
65,918
36,934
Accruals and Deferred Income
1,342,512
-418,625
80,943
294,125
895,884
262,524
916,787
Deferred Taxes & Provisions
-20,000
-126,274
100,097
46,177
-39,405
23,013
15,165
43
165
1,019
Cash flow from operations
1,766,945
-461,247
1,597,848
-1,580,097
199,997
-1,142,227
-413,563
234,056
165,338
-50,044
9,526
234,096
43,462
Investing Activities
capital expenditure
-256,919
290,609
-475,452
-60,532
-231,407
-421,176
-574,984
-316,992
-134,933
-41,145
-9,735
-10,189
-2,709
Change in Investments
-208,480
207,980
-407,980
407,980
147,480
-39,500
20,000
20,000
cash flow from investments
-48,439
82,629
-67,472
-60,532
-639,387
-568,656
-574,984
-277,492
-134,933
-41,145
-29,735
-30,189
-2,709
Financing Activities
Bank loans
Group/Directors Accounts
-265,410
-748,195
700,835
72,842
-2,531,106
2,771,034
Other Short Term Loans
Long term loans
-2,496,172
2,496,172
Hire Purchase and Lease Commitments
-154,078
-232,223
-56,290
102,684
339,907
other long term liabilities
-44,738
25,915
18,823
-70,925
70,925
share issue
-200,000
3,755,035
-660,000
50
250
interest
-24,783
-12,559
-26,505
-45,894
-45,892
-42,777
-29,303
893
809
910
1,183
896
281
cash flow from financing
-24,783
-477,969
-928,778
422,718
1,229,523
24,973
2,376,900
26,808
19,632
910
1,183
-69,979
71,456
cash and cash equivalents
cash
191,392
-1,779,677
601,598
43,989
206,163
-630,667
1,388,353
-16,628
50,037
-90,279
-19,026
133,928
112,209
overdraft
-1,502,331
-923,090
1,954,148
-583,970
1,055,243
change in cash
1,693,723
-856,587
601,598
-1,910,159
790,133
-1,685,910
1,388,353
-16,628
50,037
-90,279
-19,026
133,928
112,209
biosite systems limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for biosite systems limited. Get real-time insights into biosite systems limited's credit score, group structure and payment trends.
Perform a competitor analysis for biosite systems limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in B90 area or any other competitors across 12 key performance metrics.
biosite systems limited Ownership
BIOSITE SYSTEMS LIMITED group structure
Biosite Systems Limited has 2 subsidiary companies.
62012 - Business and domestic software development
72190 - Other research and experimental development on natural sciences and engineering
26309 - Manufacture of communication equipment (other than telegraph and telephone apparatus and equipment)
incorporation date
July 2010
age
15
incorporated
UK
ultimate parent company
ASSA ABLOY AB
accounts
Full Accounts
last accounts submitted
December 2023
previous names
pattern analytics research ltd (July 2014)
accountant
-
auditor
FORVIS MAZARS LLP
address
lancaster house drayton road, shirley, solihull, west midlands, B90 4NG
Bank
HSBC BANK PLC, HSBC BANK PLC, HSBC BANK PLC
Legal Advisor
-
biosite systems limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to biosite systems limited. Currently there are 0 open charges and 3 have been satisfied in the past.
biosite systems limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOSITE SYSTEMS LIMITED. This can take several minutes, an email will notify you when this has completed.
biosite systems limitedCompanies House Filings - See Documents
